Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
A Phase I/II Study of Bosutinib in Pediatric Patients with Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph+ Chronic Myeloid Leukemia, Study ITCC-054/COG AAML1921
Grant
Overview
Affiliation
Overview
Awarded By
PUBLIC HEALTH INSTITUTE (PHI)
Total Award Amount
61880.00
Direct Costs
45500.00
Sponsor Award Id
Affiliation
Contributor
Aman Wadhwa
Investigator
Ana Xavier
Investigator
Julie Wolfson-Stockman M.D.
Investigator
Matthew Kutny M.D.
Principal Investigator